Blanka Rizovski
Overview
Explore the profile of Blanka Rizovski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
50
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hobl E, Jilma B, Erlacher L, Duhm B, Mustak M, Broll H, et al.
Clin Exp Rheumatol
. 2011 Dec;
30(2):156-63.
PMID: 22152098
Objectives: Methotrexate (MTX) is a cornerstone in the treatment of rheumatoid arthritis (RA). Although in general MTX is very effective, the major drawback is the large inter-patient variability in clinical...
2.
Bartsch R, Steger G, Forstner B, Wenzel C, Pluschnig U, Rizovski B, et al.
BMC Clin Pharmacol
. 2007 Jul;
7:7.
PMID: 17640356
Background: A synergistic cytotoxic effect has been hypothesized for taxanes and capecitabine, a prodrug of 5-fluorouracil. Based on preclinical studies, this synergism has been attributed to an up-regulation of the...
3.
Mahnik S, Rizovski B, Fuerhacker M, Mader R
Chemosphere
. 2006 May;
65(8):1419-25.
PMID: 16713616
Little is known about the fate of cytostatics after their elimination from humans into the environment. Being often very toxic compounds, their quantification in hospital effluents may be necessary to...
4.
Mahnik S, Rizovski B, Fuerhacker M, Mader R
Anal Bioanal Chem
. 2004 Sep;
380(1):31-5.
PMID: 15365668
Cytostatic anticancer drugs are an increasingly important issue in the environmental debate, mainly due to the lack of knowledge about the fate of these toxic substances. Over the last decades,...
5.
Schmidt W, Kalipciyan M, Dornstauder E, Rizovski B, Steger G, Sedivy R, et al.
Int J Cancer
. 2004 Sep;
112(2):200-12.
PMID: 15352031
Resistance to anticancer drugs such as the widely used antimetabolite 5-fluorouracil (FU) is one of the most important obstacles to cancer chemotherapy. Using GeneChip arrays, we compared the expression profile...
6.
Fazeny-Dorner B, Mader R, Piribauer M, Rizovski B, Stogermaier B, Marosi C
Anticancer Drugs
. 2004 May;
15(5):495-8.
PMID: 15166624
Twelve patients (six female and six male) with histologically proven glioblastoma multiforme were investigated during the administration of the first cycle of dacarbazine (D; 200 mg/m) and fotemustine (F; 100...